Methylergonovine API Manufacturer in India

Swapnroop Pharma · WHO-GMP Certified · +91 87670 62101

Methylergonovine API

Methylergonovine is a semi-synthetic ergot alkaloid and a potent uterotonic agent. It acts directly on uterine smooth muscle to increase the tone, rate, and amplitude of uterine contractions. Methylergonovine is commonly supplied pharmaceutically as methylergonovine maleate.

Methylergonovine maleate is used for the prevention and control of postpartum hemorrhage by promoting sustained uterine contraction following childbirth.

Methylergonovine API Manufacturer in India

Methylergonovine Maleate is a specialized obstetric and gynecological pharmaceutical API requiring strict control of identity, assay, related alkaloids, optical rotation, pH, loss on drying and residue on ignition.

Chemical Information

CAS Number: 57432-61-8 — Methylergonovine Maleate
Molecular Formula: C20H25N3O2 · C4H4O4
Molecular Weight: 455.50 g/mol
Free Methylergonovine Formula: C20H25N3O2
Free Methylergonovine Molecular Weight: 339.43 g/mol
Drug Class: Ergot Alkaloid
Therapeutic Class: Uterotonic Agent
Therapeutic Area: Obstetrics / Gynecology
Molecule Type: Semi-synthetic Ergot Alkaloid

Mechanism of Action

Methylergonovine acts directly on uterine smooth muscle, increasing uterine tone and the rate and amplitude of rhythmic contractions. This produces a rapid and sustained uterotonic effect.

Pharmaceutical Applications

Methylergonovine Maleate API is used in pharmaceutical applications involving:

  • Postpartum hemorrhage
  • Uterine atony
  • Control of postpartum bleeding
  • Uterotonic drug development
  • Obstetric pharmaceutical formulations
  • Ergot alkaloid research

Dosage Form Applications

Methylergonovine Maleate is used in:

  • Tablets
  • Sterile injection
  • Oral pharmaceutical preparations
  • Parenteral pharmaceutical preparations

The USP describes Methylergonovine Maleate Injection as a sterile solution containing 0.2 mg/mL methylergonovine maleate.

Physical Characteristics

Methylergonovine Maleate is handled as a pharmaceutical salt. The USP specifies preservation in tight, light-resistant containers and storage in a cold place.

Manufacturing Process

A controlled Methylergonovine Maleate API manufacturing process may involve:

  1. Selection and qualification of starting materials
  2. Preparation of the ergot-derived intermediate
  3. Controlled chemical modification
  4. Formation of the methylergonovine structure
  5. Maleate salt formation
  6. Purification
  7. Crystallization
  8. Filtration
  9. Controlled drying
  10. Final analytical testing
  11. Light-protected pharmaceutical packaging

Quality Control Testing

USP monograph information provides numerical requirements for several important quality parameters, including assay, optical rotation, pH, loss on drying and residue on ignition.

Detailed Specifications

Parameter Specification
Appearance White crystalline powder or crystals
Identification IR & HPLC compliant
Assay (HPLC) 97.0%–103.0%
Loss on Drying NMT 2.0%
Residue on Ignition NMT 0.5%
pH (1% Solution) 4.4–5.2
Individual Impurity NMT 0.5%
Water Content NMT 1.0%
Get Bulk Quote via WhatsApp
chatbot/chatbot.js" defer>